InvestorsHub Logo
Followers 11
Posts 847
Boards Moderated 0
Alias Born 03/26/2011

Re: johnstockmaster post# 464

Friday, 01/29/2016 9:15:41 AM

Friday, January 29, 2016 9:15:41 AM

Post# of 27659
Hi john. Long time no hear from you.

Ever since the agreement was in placed, I had a bit of skepticism when Clearpath/RSVC hired Dr. George Siber. The reason is because He is the CSO and Executive Chairman of Genocea Biosciences Inc. that is currently developing a Herpes Simplex Virus (HSV) vaccine using an adjuvant called Matrix M which is manufactured and supplied by Isconova of Sweden that was ACQUIRED by NONAVAX last year. You familiar with Novavax? This company is pursuing and in fact in the Phase III development of RSV-F vaccine. There you go, see the big picture? Dr. Siber is the WRONG Guy supposedly to handle the collaboration for he currently serve with a company working with HSV and of course have ties with another company with a RSV in late stage development. Mymetics would have seen this as a warning beforehand.

But the good news is our HIV and Malaria vaccines candidates under preclinical development with Texas Biomed and PATH-MVI is successful according to our CEO and actively further developing the Intra-Nasal Flu vaccine. Don't we have a partner yet?

Hey we'll have 2 more new vaccine to develop (Chikungunya and Zika)
this is GREAT NEWS!


Keep Your Heads Up Fellows! We'll be fine...
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MYMX News